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Abstract 
Inflammation is initiated by the innate immune system to remove harmful stimuli and 
heal infections. Essential to this operation are multiprotein complexes, called inflammasomes, 
which process important inflammatory cytokines such as interleukin (IL)-1β and IL-18 for 
optimal host response to invasion. Infammasomes are typically comprised of one or more nod-
like receptor (NLR), a pro-caspase protease, and an adaptor molecule. NLRP3 and NLRP12 are 
NLRs with particular specificities towards certain pathogens and vaccines; however, many 
aspects of their activation remain unclear. To investigate a possible mode of assembly, we 
generated fluorescently tagged nod-like receptor pyrin domain-containing protein (NLRP) 
plasmids for transformation into cells. Expression of NLRP3 and NLRP12 inflammasome 
components was successfully observed by fluorescence microscopy. 
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Introduction 
Elimination of invasive pathogens is crucial for the survival of multicellular organisms. 
Accordingly, eukaryotic hosts have evolved various immune defense systems to sense and 
destroy invading microbes. Mammals employ two means to ensure protection: innate and 
adaptive responses. The innate immune system, which is conserved from plants to mammals, 
responds as the first line of defense. At the infection site non-specific stimuli are recognized to 
trigger inflammation, remove foreign substances, and activate the adaptive immune system. 
Through a series of highly specified processes adaptive immunity ultimately results in the 
formation of pathogen recognition and defense memories for future assaults.  
Inflammation works to create a physical barrier against the spread of contaminates as 
well as heal injured tissue. Cardinal signs of inflammation occur immediately within minutes to 
hours of infection and include pain, heat, redness, and swelling possibly in conjunction with 
dysfunction of infected areas. Although inflammation is necessary to protect the host, 
overwhelming damage or chronic inflammation can in fact be detrimental. Numerous disorders 
have been associated with persistent inflammatory stimulation including several autoimmune and 
autoinflammatory diseases.
 
This suggests close regulation of inflammatory responses is an 
essential component of proper host function.  
 The innate immune system relies on germline-encoded receptors, or pattern-recognition 
receptors (PRRs), to recognize preserved pathogen-associated molecular patterns (PAMPs) and 
danger-associated molecular patterns (DAMP) of cellular stress.
111,112
 Several families of PRRs 
have thus far been identified: toll-like receptors (TLRs), C-type lectin receptors (CLRs), retinoic 
acid-inducible gene (RIG)-I-like receptors (RLRs), and nucleotide oligomerization domain 
(NOD)-like receptors (NLRs). TLRs and CLRs can be found on the plasma membrane, while 
RLRs and NLRs reside in the cytosol of macrophages, monocytes, dendritic cells, neutrophils, 
and epithelial cells.
154 
Induction of inflammation is dependent on the TLR and NLR families. 
TLR members, in addition to those of a larger superfamily that includes interleukin-1 
receptors (IL-1Rs), are the main mammalian PRR sensors. Humans maintain ten TLRs (Table I) 
each of which are structured with amino (N)-terminal leuine-rich repeats (LRRs) and up to two 
cysteine-rich regions (CRRs).
5
 In TLR units LRRs form a horseshoe shape for sensing and 
autoregulation.
119
 The CRRs facilitate ligand binding to a broad variety of conserved bacterial, 
virus, fungi, and protozoa markers.
119
 Along the same construct a short transmembrane region 
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extends from the CRR to a Toll/Interleukin (IL)-1R (TIR) cytoplasmic tail that regulates protein-
protein interactions and signal transduction.
119
 TLRs operate either individually or as 
heterodimerers to recruit various TIR domain-containing adaptors upon stimulation.  
 
Receptor Ligand 
TLR1 Triacyl lipopeptides (Pam3CSK4) 
Soluble factors 
OspA 
Porin PorB 
TLR2 Lipoprotein/lipopeptides (Pam2CSK4, MALP2SK4) 
Peptidoglycan 
Lipoteichoic acid 
Lipoarabinomanna 
Phenol-soluble modulin 
Glycoinositolphospholipids 
Glycolipids 
Porins 
Atypical lipopolysaccharide (LPS) 
Zymosin 
Hsp70 
Hyaluronan 
Hemagglutinin 
TLR3 Poly (I-C) double-stranded RNA 
TLR4 LPS 
Taxol 
Fusion protein 
Envelope protein 
Flavolipin 
Hsp60 
Hsp70 
Type III repeat extra domain A of fibronectin 
Oligosaccharides of hyaluronic acid 
Polysaccharide fragments of heparin sulfate 
Fibrogen 
αA crystalline and HSPB8 
TLR5 Flagellin 
TLR6 Diacyl lipopeptides 
TLR7 Imidazoquinolines (imiquimod, R-848) 
Bropirimine 
Guanosine analogs 
TLR8 R-848 
TLR9 Unmethylated CpG DNA 
Chromatin-IgG complexes 
TLR10 Unknown 
Table I: Human Toll-Like Receptors and Ligands | The human toll-like receptor (TLR) family 
consists of ten receptors: TLR 1-10. A broad array of bacterial, viral, fungal, plant, insect, host, and 
synthetic stimuli activate the various TLRs. Bacterial components are recognized by TLR1, TLR2, 
TLR4-6, and TLR9. TLRs 2-4 and 9 can ligate to viral components. TLR2, 4, and 9 are furthermore 
activated by fungi, plant, and insect factors, respectively. These three TLRs also recognize host 
components. Synthetic compounds have been found to simulate TLR2, TLR7, and TLR8. No stimuli 
of TLR10 have been found yet. Other TLR ligands may exist or may be under research. 
Adapted from: Gay and Gangloff, 2007.  
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These adaptors are crucial for TLR-mediated signaling, which results in nuclear 
translocation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and 
activator protein 1 (AP-1) transcription proteins. Four proteins facilitate signal transduction: 
myeloid differentiation primary-response protein 88 (MyD88), TIR-domain-containing adaptor 
protein (TIRAP) also known as MyD88-adaptor-like protein (MAL), TIR-domain-containing 
adaptor protein including interferon beta (IFN-β) (TRIF), and TRIF-related adaptor molecule 
(TRAM). TIRAP and TRAM provide specificity for TLR3- and TLR4-mediated signaling.
5 
Typically, TLRs signal via MyD88-dependent pathways with the exception of TLR3, which 
exclusively operates by TRIF-dependent/MyD88-independent pathways. MyD88 utilizes death 
domain (DD) interactions to transmit activation signals through two major signal pathways. DDs 
are part of the death-fold domain family, which also includes the death effector domain (DED), 
caspase recruitment domain (CARD) and pryin domain (PYD). These domains are capable of 
forming dimers or multimers with other members of the same subfamily to mediate apoptosis 
signals. 
One MyD88 signal pathway for NF-κB activation involves family members p65 and 
p105 successor molecule p50. p65 and p50 form a heterodimer inactive molecule directly 
attached to a nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor (IκB) 
protein complex.
78,80
 Upon MyD88 signaling phosphorylation of IκB by multiprotein IκB kinase 
(IKK) allows NF-κB to move into the nucleus.78,80 The second pathway, for activation of AP-1, 
relies on mitogen-activated protein kinases (MAPKs). MAPKs rapidly respond within the cell to 
a diverse array of events to regulate proliferation, gene expression, differentiation, mitosis, cell 
survival, and apoptosis.
122
 When phosphorylated by mitogen-activated kinase kinases (MKKs) 
MAPK members c-jun N-terminal kinase (JNK) and p38 freely translocate to the nucleus where 
they in turn phosphorylate AP-1 residues to form a mature dimeric structure.
89,146  
Within the 
nucleus both NF-κB and AP-1 transcribe and release pro-inflammatory cytokines interleukin 
(IL)-1β and interleukin-18 (IL-18) to the cytosol. 
Interlukin-1 beta (IL-1β) and Interlukin-18 (IL-18) are especially important pro-
inflammatory cytokines that recruit phagocytic lymphocytes and endothelial cells to the infection 
site.
34,131 
Mature IL-1β has a strong ability to penetrate injured areas and adhere intercellular and 
endothelial molecules.
16
 IL-18 stimulates production of another cytokine with similar function 
called interferon-gamma (IFN-γ).140 Further, it enhances cytolytic activity of natural killer cells 
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(NK), which attack invading, infected, or transformed cells as well as secrete toxic proteins to 
propagate immune response.
140
 These two cytokines have been linked to afflictions including 
fever syndromes, vitiligo, Crohn’s disease, gout, asbestosis, silicosis, Alzheimer’s disease, septic 
shock, and several other autoinflammatory and autoimmune disorders.
49,131
 Moreover, IL-1β 
related syndromes have responded to interleukin-1 receptor antagonist (IL-Ra) therapies.
36,51
 
While the exact mechanisms leading to secretion are not fully understood several models 
proposed involve secretion by exosome vesicles and shedding of vesicles from or directly 
through the plasma membrane by unidentified transporters.
10,18,102,138
 Release of IL-1β and IL-18 
is dependent on the conversion from inactive precursors pro-IL-1β and pro-IL-18, respectively, 
to their mature active form. Caspase-1 is fundamental for production of IL-1β and IL-18, 
although other independent mechanisms have been acknowledged.
161
  
Caspase proteases initiate protein catabolism and can be classified into subgroups based 
on whether their function is related to inflammation, group I, or apoptosis, group II or III.
96 
The 
human inflammatory caspases include caspase-1, caspase-4, caspase-5, and caspase-11.
81,110
 
Caspase-1, previously known as IL-1β converting enzyme (ICE), is involved in cleavage of 
inactive interlukin pro-forms IL-1β, IL-18, and IL-33 as well as pro-caspase-7. On top of its role 
in apoptosis activation, this inflammatory mediator facilitates pyropotic cell death via cell lysis 
when triggered by DNA fragmentation or pore formation.
47,92 
Somewhat similar to mature IL-1β 
and IL-18, formation of caspase-1 involves the activation of zymogen pro-caspase-1.
24,156 
Pro-
caspase-1 contains an N-terminal CARD followed by 10-kilodalton (p10) and 20-kilodalton 
(p20) domains. Upon activation apoptosis-associated speck-like protein containing CARD (ASC) 
recruits and autoprocesses pro-caspase-1 to a p10-p20 heterodimer structure with two active 
sites.
24,44,108,171 
ASC is an adaptor protein, made of PYD and CARD, that is necessary for 
caspase-1 activation.
13,44,46,71,76,104,106,109,144 
NLR members also function with ASC to process 
caspase-1. 
The NLR family is comprised of twenty-three human genes primarily expressed by 
macrophages and dendritic cells. Its central nucleotide-binding oligomerization domain 
(NACHT/NOD) is structurally conserved and oligomerizes for signaling. NACHT is commonly 
flanked by carboxy (C)-terminal LRRs and an N-terminal effector domain.
145
 N-terminal 
domains include CARD, PYD, the baculoviral inhibitor of apoptosis repeat (BIR), and 
transactivator domain (AD).
145
 There exist four NLR subfamilies which can be classified based 
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on their respective N-terminus: NLRAs (CIITA), NLRBs (NAIP), NLRCs (NOD1-2, NLRC3-5, 
NLRX1), and NLRPs (NLRP1-14) (Figure I). NLRs with a CARD N-terminal recruit CARD-
containing molecules to initiate transcription of pro-inflammatory genes, such as cytokines, 
whereas those with PYDs recruit other PYDs to bridge protein processing of pro-inflammatory 
caspases.
152,153
 Like other inflammatory components, the NLRs have extensively been associated 
with multiple disorders (Table II). 
 
Figure I: Human Nod-Like Receptor Subfamilies, Functions, and Associated 
Disorders | Nod-like receptors (NLRs) are organized by into four subfamilies based on 
their N-terminal domain, which plays a role in signal transduction and protein-protein 
interactions. NLRA receptor class II, major histocompatibility complex, transactivator 
(CIITA) contains transactivator domain (AD); NLRB receptor neuronal apoptosis 
inhibitory protein (NAIP) holds baculoviral inhibitor of apoptosis repeat (BIR); NLRCs 
nucleotide-binding oligomerization domain-containing proteins (NOD) 1-2, and NLRC3-
4 have caspase recruitment domain (CARD); and NLRPs NLRP1-14 contain pryin 
domain (PYD). Additionally all NLRs have a nucleotide-binding oligomerization 
(NACHT) domain, that can oligomerize for signaling, and leuine-rich repeats (LRRs), 
which sense and bind ligands. NLR10 does not contain LRRs.  
Adapted from: Conforti-Andreoni, Ricciardi-Castagnoli, & Mortellaro, 2011 and Nod-
Like Receptors Review, 2012. 
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 Function Associated Disorders 
CIITA Tans activates class II major histocompatibility complex
151 
Bare lymphocyte syndrome type II1
151 
Rheumatoid arthritis
66 
Multiple sclerosis
11 
Graves disease
150 
 Toxic shock syndrome
147
 
Hodgkin’s lymphoma130 
NAIP Prevents motor-neural apoptosis
100
  Spinal muscular atrophy
141 
Amyotrophic lateral sclerosis
68 
Legionnaires’ disease166 
NOD1 Caspase-9-mediated apoptosis
17,67 
Increases proliferation and effector function of T-cells
163 
Inflammatory bowel diseases
113 
NOD2 Bacterial LPS recognition
88 Crohn’s disease29 
 Blau syndrome
117 
 Takayasu disease
98 
NLRC3 T-cell activatioin
28 
Negative regulator of NF-κB143 
Wegener’s granulomatosis94 
NLRC4 Apoptosis
53 Legionnairs’ disease165 
Inflammasome assembly
139 
Olfactory neuroblastoma
168 
NLRC5 Regulates NF-κB31,81 Legionnairs’ disease129 
Type I & II interferon signal pathways
31,87 
Diabetes mellitus
25 
NLRX1 Regulates MAVS-mediated response
121 
Shigellosis
155 
NF-κB signaling155 Chlamydia trachomatis3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
NLRP1 Caspase-9 and caspase-3 mediated apoptosis
101,107 
Inflammasome assembly
139
 
Vitiligo
40 
Anthrax disease
118
 
Nodular malignant melanoma
164 
Celiac disease
135 
Kawasaki disease
128 
Addison’s disease176 
NLRP2 Suppresses NF-κB20  
Inflammasome assembly
4 
Gonorrhea
50 
Beckwith-Wiedemann syndrome
115 
NLRP3 Apoptosis
103, 126 
Inflammasome assmebly
139 
Cryopyrin-associated periodic syndromes
61,6,142,45
 
Gout
85 
Hives
136 
NLRP4 Regulates type I interferon signal pathway
32 
 
NLRP5 Progression of zygote beyond primary embryonic cell divisions
159 
Polyendocrine syndrome type I
7 
NLRP6 Colon inflammatory response
26 
Negative regulator of NF-κB9 
Inflammasome assembly
139 
Periodontitis
15 
Nonalcoholic steatohepatitis
58 
NLRP7 IL-1β secretion86 
Inflammasome assembly
83 
Hydatidiform mole development
123 
NLRP8 Inflammation potential Pancreatic carcinoma
114 
Rheumatoid arthritis
42 
NLRP9 Inflammation potential Systemic-onset juvenile idiopathic arthritis
154 
NLRP10 IL-1β secretion167 
PYD-mediated apoptosis
167 
 
NLRP11 Inflammation potential Crohn’s disease33 
NLRP12 NF-κB activation8 
Inflammasome assembly
139 
Colon inflammation & tumorigenesis
8 
Plague
162 
NLRP12-assciated periodic syndrome
69 
NLRP13 Inflammation potential  
NLRP14 Inflammation potential 
Spermatogenesis potential
169 
Azoospermia
169 
Table II: Functions and Associated Disorders of NLRs | Functions of all human NLRs 
are related to cell apoptosis, inflammation, or production of inflammatory mediators. 
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Multiple autoinflammatory and autoimmune disorders have been associated with                                                 
malfunction of these receptors. 
 
Several NLR or pyrin and HIN200 domain-containing protein (PYHIN) members along 
with a pro-caspase and, generally, ASC assemble to form multiprotein inflammasome complexes 
that initiate the processes of inflammation. Currently nine PRRs are known to form caspase-1 
containing inflammasomes: PYHIN subfamilies absent in melanoma 2 (AIM2) and interferon-
induced protein 16 (IFI16), and NLR constituents NLRC4, NLRP1, NLRP2, NLRP3, NLRP6, 
NLRP7, and NLRP12 (Figure II).
4,65,83,139,149
 Only one homooligermized inflammasome per cell 
has been observed to form to date.
46
 
 
Figure II: Caspase I Activating Inflammasomes and Activators | Nine 
inflammasomes are known to process pro-caspase-1 to mature caspase-1 upon assembly: 
absent in melanoma 2 (AIM2), interferon-induced protein 15 (IFI16), and nod-like 
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receptors NLRC4, NLRP1-3, 7, 6, and 12. Their homooligomerized structures with pro-
caspase and apoptosis-associated speck-like protein containing CARD (ASC) adaptor 
protein are illustrated. Pyrin and HIN200 domain containing protein (PYHIN) 
subfamilies AIM2 and IFI16 are activated by double-stranded DNA. Particularly, IFI16 is 
assembles in the presence of nuclear double-stranded DNA. NLR members NLRC4, 
NLRP1, NLRP2, NLRP7 and NLRP12 are stimulated by bacterial components. NLRP12 
has only been found to respond to Yersinia pestis, the causative agent of plague. NLRP6 
is activated by microflora. In addition to intracellular stimuli, NLRP3 recognizes a broad 
variety of pathogen and danger signals. 
 
Two signals have been suggested as a requirement for inflammasome oligomerization. 
First, a priming signal via TLR pathways results in transcript of pro-IL-1β and pro-IL-18. Next a 
second signal leads to indirect stimulation of the NACHT domain, which self-oligomerizes to 
recruit ASC via its CARD or PYD. In turn, ASC uses CARD to autocleave pro-caspase-1 into 
caspase-1 for subsequent maturation and secretion of pro-IL-1β and pro-IL-18 cytokines or 
pyroptosis.
153
 Detailed mechanisms of inflammasome assembly and signaling remain unknown. 
Based on the vast number of inflammatory and immune related diseases and unclear 
understanding of inflammation processing it is obvious that the role of NLRs in inflammation 
and homeostasis begs for further inspection. This study will focus on the NLRP3 and NLRP12 
inflammasomes. 
NLRP3, also known as cyropyrin, NALP3, or PYPAF1, is the most extensively 
characterized inflammasome. It is activated by a number of structurally diverse ligands through 
sense of general cellular stress as well as direct and indirect recognition of activation 
signals.
64,71,134,175
 Stimulators include antibacterial, viral, fungal and parasitic microbial stimuli; 
crystalline or accumulated particulate substances such as asbestos, silica, uric acid, Abeta 
peptides, etc; pore-forming toxins, low intracellular potassium amounts, and/or calcium influx; 
extracellular adenosine triphosphate (ATP) or necrotic cell components; and reactive oxygen 
species (ROS).
38,39,41, 55-57,63,64,75,97,106,109,124,134 
Three main models for activation of the NLRP3 
inflammasome have been offered (Figure III). One mechanism suggests ATP acts as a DAMP 
released at sites of cellular injury and necrosis. Through the purinergic P2X7 receptor, an ATP-
gated ion channel, this stimulates rapid potassium (K
+
) efflux, which in turn triggers recruitment 
and pore formation of pannexin-1 hemichannel.
74,77
 To counteract membrane depolarization by 
K
+
 efflux, calcium (Ca
2+
) influx may be promoted.
122
 Either sense of low intracellular potassium, 
high intercellular calcium, breakdown of membrane integrity, or pore formation leads to NLRP3 
inflammasome assembly.
74,77,122
 A second model proposes that incomplete clearance of 
phagocytosed particulates or crystalline material leads to membrane disruption. Phagosomal 
  
12 
 
destabilization then releases proteinase cathepsin B into the cytosol activating the 
inflammasome.
38,125
 The exact role of cathepsin B for activation is still under examination.
38,125
 
All activators, including the two aforementioned means, induce ROS. Normally, ROS is 
produced though cellular metabolism in resting cells as a compound with thioredoxin-interacting 
protein (TXNIP) bound to oxidoreductase thioredoxin (TRX). Although ROS is not sufficient, a 
third model for NLRP3 activation believes cellular infection or stress increases ROS levels 
causing dissociation of TXNIP from TRX and increase in oxidative stress.
22,30,38,133,175
 
Dissassociation of TXNIP allows for ROS interaction and assembly of the inflammasome.
175 
Additionally, upregulation of NLRP3 is seen to positively affect activity of the  inflammasome.
13
 
A number of autoinflammatory cryopyrin-associated periodic syndromes (CAPS) are associated 
with this inflammasome’s activity including familial cold autoinflammatory syndrome (FCAS), 
Muckle-Wells syndrome, neonatal-onset multisystemic inflammatory disease (NOMID), 
chroming infantile neurological cutaneous and articular syndrome (CINCA), and familial 
Mediterranean fever.
45,49,93,134,157 
The inflammasome also plays a in gout pathogenesis and tumor 
surveillance.
85 
 
Figure III: NLRP3 Inflammasome Activation | Assembly of the NLRP3 
inflammasome requires two signals. (1) Pro-interleukin (IL)-1β and pro-IL-18 must first 
be transcribed and secreted to the cytosol. Two toll-like receptor (TLR) and interleukin-1 
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receptor (IL-1R) stimulated pathways involving toll/interleukin-1R (TIR) containing 
adaptor proteins such as myeloid differentiation primary-response protein 88 (MyD88) or 
TIR-domain-containing adaptor protein including interferon beta (TRIF) are activated for 
pro-cytokine transcription by nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF-κB) and activator protein-1 (AP-1) transcription proteins. TIR-domain-
containing adaptor protein/MyD88-adaptor-like protein (TIRAP/MAL) and TRIF-related 
adaptor molecule (TRAM) provide specificity some TLR-mediated signaling. NF-κB 
translocates to the nucleus after nuclear factor of kappa light polypeptide gene enhancer 
in B-cells inhibitor (IκB) kinases (IKK) to phosphorylate IκB from NF-κB family 
member p65 and successor p50. Similarly, AP-1 forms in the nucleus after 
phosphorylation of c-jun N-terminal kinase (JNK) and p38 by mitogen-activated kinase 
kinases (MKKs). (2) A variety of secondary signals initiate inflammasome 
oligomerization with ASC and pro-caspase-1. Signals include danger-associated 
molecular pattern (DAMP) adenosine triphosphate (ATP) that stimulates rapid potassium 
(K+) efflux through the purinergic P2X7 receptor, which in turn triggers pore formation of 
pannexin-1 hemichannel. K+ efflux may promote calcium (Ca2+) influx. Additionally, 
incomplete clearance of phagocytosed particulates or crystalline materials can trigger 
phagosomal membrane destabilization and release of cathepsin B to the cytosol. These 
activators induce reactive oxygen species (ROS) to release thioredoxin-interacting 
protein (TXNIP) from oxidoreductase thioredoxin (TRX). TXNIP interacts with NLRP3 
during inflammasome assembly. Upon assembly pro-caspase-1 is rapidly autoprocessed 
to caspase-1, which then either begins pyroptosis or cleavage of pro-IL-1β and pro-IL-18 
to mature cytokines IL-1β and IL-18 and secretion of active cytokine forms.  
Adapted from: R&D Systems, 2010. 
 
Monarch-1, also known as NLRP12, has not extensively been studied. Notably, it was the 
first NLR to show interaction with ASC for formation of an IL-1β mature inflammasome by 
biochemical assay.
166
 In addition to caspase-1-dependent cytokine processing, NLRP12 plays a 
role in regulation of NF-κB and hypersensitvity.12,48,99,158 Curiously, NLRP12 expression differs 
in various diseases where it may exhibit either inflammatory or inhibitory functions.
73,166,170,173
 In 
some cases, such as hereditary period fever (HPF), mutations in the domain are associated with 
gain-of-function, similar to that of cyropyrin-associated periodic syndromes caused by mutations 
in NLRP3.
69
 However while the NLRP3 associated diseases result from single nucleotide 
missense mutations, additional NLRP12 periodic fever mutants have been identified as splice 
variants that show loss-of-function.
69
 Furthermore, this inflammasome is linked to collagen fibril 
degradation, tumors, complete x-linked congenital stationary night blindness, and resistance to 
Yersinia pestis.
59,120,137,160,162 
Survival of Y. pestis within the host strongly relies on avoiding activation of the innate 
immune defenses.
162 
Interestingly, in addition to NLRP12, the bacterium has been found to 
stimulate other inflammasomes such as NLRP3, NLRC4, but not AIM2.
174 
Moreover, NLRP12 
deficiency was not sufficient for complete reduction of mature cytokine secretion after its 
exposure.
162 
This, as well as structural similarities between NLRP3 and NLPR12, their link to 
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several inflammatory and immune diseases, and that both interact by ASC and pro-caspase-1 
association suggests several inflammasomes may work together for optimal host response to 
pathogens.
  
Here we sought to complete expression studies by fluorescence microscopy of NLRP3 
and NLRP12 for future analysis of a possible mode of inflammasome assembly. Cerulean and 
mCherry dyes were selected to generate NLRP3 and NLPR12 fluorescent tagged plasmids, 
respectively. To purify the product and decrease vector background the cerulean vector was 
treated with calf-intestinal alkaline phosphatase (CIP) prior to ligation with the NLRP3 insert. 
Plasmids were transfected into human macrophages at several overexpressed concentrations 
alone and together, but failed to show NLRP expression. Due to difficulties with macrophage 
transformation this cell type was abandoned. Following transfection of the plasmids into human 
embryonic kidney T-cells (HEK293-T) expression of NLRP3 and NLRP12 inflammasome 
components was successfully observed.  
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Materials and Methods 
Preparation of NLRP Color Tagged Constructs 
Vector pRZ-LmCitrz-FLAG was dephosphorylated with 10μL calf-intestinal alkaline 
phosphatase (CIP) for 60 min at room temperature and purified with MP Biomedicals Geneclean 
Spin Kit (cat. #1101-400). To create plasmid pRZ-mNLRP3-l-c-HA (NLRP3-cerulean), a 20μL 
total reaction with NLRP3 insert was ligated to the vector (1:6μL) using a New England BioLabs 
T4 DNA ligase (cat. #M0202S) and buffer (cat. #B0202S) for 15 min at room temperature. The 
mNLRP12huo-mCherrypRB (NLRP12-mCherry) plasmid was previously ligated (NLRP12 
inserted in pRZ-LmmCherry-HA) by and obtained from Gregory Vladimer. 
 
 
Plasmid Identification 
NLRP3-cerulean was digested with New England BioLabs restriction endonuclease XhoI (cat. 
#R0146S) for 60 min at 37
o
 C. Electrophoresis of plasmid was run on 3% agarose gel with a 1kb 
ladder. NLRP12-mCherry was digested with restriction enzymes XhoI and New England 
BioLabs BsiWI (cat. #R0553S). A 1% agarose gel with 100bp ladder was used for 
electrophoresis of plasmid. NLRP12-mCherry was sequenced by GENEWIZ. 
 
 
Plasmid Growth, Replication, and Purification 
Plasmid NLRP3-cerulean was transformed into Invitrogen Max Efficiency DH10 Bac chemically 
competent cells (cat. #10361-012) (1:50μL) and grown on lysogney broth (LB) ampicillin 
(AMP) plates overnight at 37
o
 C. Single colonies were selected for mini culture growth in 3mL 
LB with 3μL AMP. Cultures shook at 37o C overnight and a total of 4.5mL was used for maxi 
culture growth. 200mL LB broth enriched with 200μL ampicillin and cell culture was allowed to 
shake at 37
o
 C overnight. Qiagen Endofree Plasmid Maxi Kit (cat. #12362) was used for cell 
purification. Concentrations of plasmids were found to be 788.4ng/μL (1.89/2.27) NLRP3-
cerulean and 644.3ng/μL (1.90/2.34) NLRP12-mCherry using a NanoDrop Spectrophotometer. 
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Cell Culture 
Human embryonic kidney (HEK293) T-cells were grown in Lonza Biowhittaker
TM
 Dulbecco’s 
Modified Eagle Medium (DMEM) with 4.5g/L glucose and L-glutamine (cat. #12-604F). 5% 
Fetal calf serum (FCS) and 10μg/mL ciprofloxacin (CIPRO) were supplemented into media. 
Cells grew to confluence at 37
o
 C in 5% CO2. 
 
 
Cell Plating 
First, media was removed from cells before washed with 3mL phosphate buffered saline (PBS). 
PBS was removed and 500μL trypsin was used to detach cells. Cells were spun at 2000 RPM for 
five minutes and pellet resuspended in 2mL DMEM+FCS+CIPRO media. A 3x3 grid 
hemocytometer was used to count cells. Cells were diluted to 8 x 10
5 
cells/well with the 
DMEM+FCS+CIPRO media. 250μL of cell media were plated into the center four square Lab-
Tek® II Chamber Slide
TM
 System glass chambers (cat. #154534). Cells incubated at 37
o
 C in 5% 
CO2 overnight. 
 
 
Cell Transfection 
Working stocks of plasmids were diluted to 10ng/μL with PBS. 25μL of Invitrogen GIBCO® 
DMEM high glucose 1x media with 4.5g/L D-glucose and L-glutamine but no sodium pyruvate 
(cat. #11965) was added to the determined amount of plasmid DNA in a 96 well plate and 
allowed to sit for 5 minutes. 5μL of a FCS-free DMEM and 4μL Novagen GeneJuice 
transfection reagent (cat. #70767 M00066223) mixture was added to the plates. After 15 min 
50μL of plated cells was removed from the glass chambers and the transfection mixture was 
added. NLRP-color plasmids were transfected at various concentrations: NLRP3 – 10, 50ng/μL; 
NLRP12 – 10, 50, 100ng/μL; and NLRP3:NLRP12 – 10:10, 50:50, 10:50, 50:10, 100:100ng/μL. 
Plates were incubated at 37
o
 C in 5% CO2 for 24-48 hrs. 
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Cell Expression Analysis by Confocal Microscopy 
To fix cells for imaging media was first removed and cells washed with 250μL PBS. PBS was 
then removed and cells fixed with 50μL PBS and 50μL USB paraformaldehyde solution in 4% 
PBS (cat. #11943) for 5 min. Fix solution was discarded and cells washed with 200μL PBS 
before chamber walls were removed from the glass slide. Leica TCS SP2 spectral confocal and 
multiphoton system was used for fluorescence microscopy analysis. 
 
 
Figures and Images 
Figures were created using Microsoft PowerPoint and Microsoft Paint. Confocal images were 
visually enhanced using Adobe Photoshop. 
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Results 
 Some members of the nod-like receptor (NLR) family assemble to create protein 
complexes capable of processing pro-caspase-1 to active caspase-1 for the subsequent maturation 
and secretion IL-1β and IL-18. Protease caspase-1 and cytokines IL-1β and IL-18 play especially 
important roles in inflammatory response of the innate immune system. Several 
autoinflammatory and infectious diseases have been associated with chronic and overwhelming 
inflammasome activity. Although inflammation is essential for the body and its malfunction can 
be devastating, relatively little is known about activation and assembly of inflammasomes. 
Recent studies have found only one inflammasome structure forms per cell; however some 
pathogens such as the plague agent, Yersinia pestis, can stimulate multiple inflammasomes.
162
 
NLRP3 and NLRP12 are two inflammasomes activated by Y.pestis.
162
 Here we created 
fluorescent color tagged NLRP plasmids for use in expression studies by confocal microscopy 
and future experiments to understand possible mechanisms of inflammasome assembly. 
 First, appropriate fluorescent color tags needed to be attached to NLRP cDNA. 
Previously NLRP12 was ligated to vector pRZ-LmmCherry-HA. After digestion with restriction 
enzymes XhoI and BsiWI the NLRP12-mCherry plasmid was run on a 1% agarose gel with a 
100bp ladder. Photography of gel (Figure IA) shows correct approximate band sizes of the 
vector at 1200bp and the NLRP12 insert at 1000bp. Additionally, to verify both color tag and 
cDNA were correctly ligated, the plasmid was sequenced by GENEWIZ (Figure IB). Excitation 
of the mCherry dye overlaps the emission of fluorescent dye cerulean; thus, it was chosen as the 
color tag for NLRP3. pRZ-LmCitrz-FLAG was ligated to NLRP3 cDNA to make the pRZ-
mNLRP3-l-c-HA plasmid. The NLRP3-cerulean plasmid was digested with XhoI and ligation 
was verified by gel electrophoresis on 3% agarose gel with a 1kb ladder (Figure IC). The 
NLRP3 fragment is seen between 7kb and 8kb. Due to lack of resources, NLRP3-cerulean 
ligation could not be verified by double digestion. Furthermore, although attempts to sequence 
the plasmid were made, sequencing results failed. A NanoDrop Spectrophotometer was utilized 
to find the plasmid concentrations to be 788.4ng/μL of NLRP3-cerulean and 644.3ng/μL 
NLRP12-mcherry. 
 Next, the plasmids needed to be transformed into cells for analysis. The NLRP plasmids 
were diluted to 10ng/μL working stocks with phosphate buffered saline (PBS). These stocks 
were used with a DMEM high glucose 1x media with 4.5g/L D-glucose and L-glutamine but no 
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sodium pyruvate and GeneJuice mix for the transformation. Plasmids were transfected into 
human embryonic kidney (HEK293) T-cells at various concentrations: 10 and 50ng/μL NLRP3-
cerulean alone; 10, 50, and 100ng/μL of NLRP12-mCherry alone; and 10:10, 50:50, 10:50, 
50:10, and 100:100ng/μL NLRP3-cerulean:NLRP12-mCherry. Transfected cells incubated 
between 24-48 hours at 37
o
 C in 5% CO2 prior to confocal viewing.  
 To view the cells by microscopy they were fixed to the glass slides with 
paraformaldehyde solution. The confocal system was adjusted to excite NLRP3-cerulean and 
NLRP12-mCherry at 450nm and 590nm, and produce emissions at 500nm and 630nm 
respectively. Areas with single layer cells are necessary for viewing fluorescence. Images of 
NLRP3 (Figure IIA) and NLRP12 (Figure IIC) transformed cells in single layer growth were 
photographed. The fluorescence displays at these points were adjusted to capture two images 
showing possible inflammasome assembly. NLRP3 inflammasome component assembly (Figure 
IIB) at 50ng/μL overexpression alone and NLRP12 inflammasome component assembly (Figure 
IID) at the same concentration alone were observed. Both obtained fluorescent images showed 
background noise as indicated by the dispersed and weak fluorescence signaling. Somewhat 
steady signaling was seen in the areas of fluorescence grouping. The fluorescence images were 
overlapped on their corresponding single layer cell images to further examine the signals. The 
proposed NLRP3 expression (Figure IIE) and NLRP12 expression (Figure IIF) was seen to 
reside within the cells. Foremost this indicates that the pRZ-mNLRP3-l-c-HA plasmid was a 
successful ligation of NLRP3 cDNA into the cerulean color vector. Additionally, both plasmids 
show capability of exhibiting inflammasome component expression when transformed into 
HEK293 T-cells. 
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Discussion 
Inflammation is a necessary attempt of the innate immune system to remove harmful 
stimuli and heal the host. However chronic or overwhelming inflammatory response can be 
detrimental to the host. Our current understanding of inflammation mechanisms and activation 
remains incomplete. The prevalence of inflammatory dysfunction attributed diseases confirms 
the need to further investigate this innate response.  
Multiprotein complexes called inflammasomes have been found to initiate inflammation. 
They are constructed with members of the nod-like receptor (NLR) or pyrin and HIN200 
domain-containing protein (PYHIN) family as well as a pro-caspase protease and apoptosis-
associated speck-like protein containing CARD (ASC) adaptor protein. Inflammasomes involved 
in autoprocessing of mature caspase-1 are of particular importance because they lead to the 
cleavage of certain pro-inflammatory cytokines, which play a large role in inflammation 
initiation. Secretion of mature interleukin (IL)-1β and IL-18 are the result of caspase-1 
processing inflammasomes. NLRP3 and NLRP12 are two subfamily NLR members capable of 
forming inflammasomes that lead to caspase-1 and subsequently IL-1β and IL-18. So far only 
one inflammasome per cell has been observed to form.
153
 Interestingly, some pathogens such as 
Yersinia pestis, which is responsible for plague, stimulate multiple inflammasomes.
162
 In 
particular the NLRP3 and NLPR12 inflammasomes are two complexes that are activated. This 
raises several questions about the assembly of inflammasomes. 
Previously, antibody microscopy studies of protein interactions have caused problems 
due to weak sensitivity. Instead of this traditional approach we considered fluorescence 
microscopy.  Here we created fluorescent tagged NLRP3 and NLPR12 plasmids for expression 
studies. First, NLRP cDNA was ligated to a vector tagged with cerulean dye to produce plasmid 
pRZ-mNLRP3-l-c-HA. The mNLRP12huo-mCherrypRB plasmid was previously created and 
obtained for these experiments. Use of retroviral plasmids is a future option. NLRP12-mCherry 
was double digested and run on an agarose gel to roughly determine if the ligation was 
successful. Both the vector and insert fragments were seen on the gel. Additionally, the plasmid 
was sequenced to verify proper ligation. The NLRP3-cerulean plasmid was single digested and 
when run on an agarose gel showed the NLRP3 insert fragment. Sequencing of the plasmid 
failed despite several attempts, so the gel confirmation was determined to be sufficient to 
proceed. Nevertheless, it is recommended this plasmid is sequenced for verification purposes.  
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Both plasmids were then transfected into human embryonic kidney (HEK293) T-cells at 
various concentrations alone and mixed together. HEK293 T-cells are easily transfected; 
however more natural immune cells, such as macrophages, exist. Studies of expression in 
macrophages or other natural cells may aid in better understanding of pathogen activation of 
inflammasomes. The transfected cells were viewed using confocal microscopy. Inflammasome 
component expression of NLRP3 and NLRP12 alone at 50ng/μL concentration resulted, but the 
amount of background and weak signaling must also be considered. Foremost the results indicate 
the NLRP3-cerulean plasmid was successfully created. Mixed inflammasome component 
expression was not seen in any NLRP3-NLRP12 double transfected cells.  
Cerulean and mCherry color dyes were ideal selections for fluorescence studies because 
the excitation wavelength of mCherry overlaps the emission wavelength of cerulean. Thus, the 
plasmids created for study of inflammasome expression in this project can be of use in future 
fluorescence resonance energy transfer (FRET) studies. FRET is a radiationless tool used to 
investigate molecular interactions. It relies on distance-dependent transfer of energy from donor 
to acceptor molecule to produce a resonant fluorescence. When the donor molecule, a dye or 
chomophore, absorbs the initial energy and transfers it to the acceptor molecule. This transfer of 
energy results in reduction of donor fluorescence intensity and excited state lifetime, and 
increases the acceptor’s emission intensity.60 Proper FRET analysis is dependent on certain 
primary conditions such as distance, fluorescence spectral overlap, and sufficient concentrations 
of both molecules. Since we know the fluorescent tagged plasmids are able to express the 
inflammasomes and appropriate color dyes were selected, favorable transformation 
concentrations of the plasmids should be found for mixed expression studies by FRET. Once the 
concentrations are determined this may be used to investigate whether several NLR family 
members homooligermize or assemble as heteroligomerized protein complexes for optimal host 
innate immune response. 
Additionally, cells may need to be stimulated with inflammasome activators such as 
lipopolysaccharide (LPS). The results here, and with all overexpression studies, should be taken 
with caution. Overexpression of DNA may lead to spontaneous aggregation without ligand 
stimulation. Furthermore, overexpression of the protein tests on higher than normal protein 
levels, which is suboptimal for understanding real protein interactions. Overall, further studies 
are suggested to help pave way for infectious disease and inflammatory syndrome drug targets. 
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Figures and Tables 
 
A               C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
Figure I: NLRP cDNA Ligation to Color Tags | NLRP cDNA was ligated to distinct 
color tags for fluorescence imaging. Plasmids were then digested and photographed after 
gel electrophoresis. (A) The NLRP12-mCherry plasmid was double digested and run on a 
1% gel. NLRP12 and vector fragments are seen close to each other around 1,000bp. (B) 
Additionally the plasmid was sequenced by GENEWIZ. Sequencing shows the mCherry 
fluorescence gene ligated prior to NLRP12. (C) The second plasmid was a NLRP3-
cerulean ligation. NLRP3-cerulean was run on a 3% gel after single digestion and 
subsequently photographed. The gel shows the NLRP3 insert fragment between 7-8kb. 
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A       B      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C       D 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
E        F 
 
 
 
 
 
 
 
 
 
 
 
Figure II: Inflammasome Assembly | (A) NLRP3 transformed cells were photographed 
at single layer cell growth. (B) Expression of NLRP3 inflammasome components is 
represented by blue fluorescence color. Areas of clumped coloring is possible 
inflammasomes expression at 50ng/μL. (C) Similarly, single layer cells of NLRP12 
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transformed cells were photographed. (D) Fluorescent NLRP12 inflammsome component 
expression is seen as red coloring at concentration 50ng/μL. (E) Cells and NLRP3 
fluorescence images were overlayed to show the full inflammasome component 
expression map. Fluorescence is seen to reside within the cells, supporting the belief of 
suspected inflammasome component expression. (F) The same was done for NLRP12 
cells and fluoresent imaging, also showing fluorescence located within the cell. 
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